For which adults with gouty arthritis is canakinumab (Ilaris) indicated?

Canakinumab (Ilaris) is indicated for symptomatic treatment of adults with frequent gouty arthritis attacks (at least 3 in the previous 12 months) for whom NSAIDs and colchicine are contraindicated, not tolerated or inadequately effective, and repeated corticosteroid courses are inappropriate.